白桦
生物
茉莉酸甲酯
白桦酸
三萜
白桦素
脱落酸
羽扇豆醇
生物化学
次生代谢
基因表达
基因
生物合成
植物
遗传学
替代医学
病理
医学
作者
Jing Yin,Jie Yang,Hongsi Ma,Tian Liang,Ying Li,Jialei Xiao,Hongmei Tian,Zhiqiang Xu,Yaguang Zhan
出处
期刊:Plant Science
[Elsevier BV]
日期:2020-02-03
卷期号:294: 110433-110433
被引量:11
标识
DOI:10.1016/j.plantsci.2020.110433
摘要
Triterpenoids produced by the secondary metabolism of Betula platyphylla Suk. exhibit important pharmacological activities, such as tumor inhibition, anti-HIV, and defense against pathogens, but the yield of natural synthesis is low, which is insufficient to meet people's needs. In this study, we identified two OSC genes of birch, named as BpCAS and Bpβ-AS, respectively. The expression of BpCAS and Bpβ-AS were higher levels in roots and in stems, respectively, and they induced expression in response to methyl jasmonate (MeJA), gibberellin (GA3), abscisic acid (ABA), ethylene and mechanical damage. The function of the two genes in the triterpene synthesis of birch was identified by reverse genetics. The inhibition of Bpβ-AS gene positively regulates synthesis of betulinic acid. BpCAS interference can significantly promote the upregulation of lupeol synthase gene (BPW) and β-amyrin synthase gene(BPY), and conversion of 2,3-oxidosqualene to the downstream products betulinic acid and oleanolic acid. This study provided a basis for the genetic improvement of triterpenoid synthesis in birch through genetic engineering. The obtained transgenic birch and suspension cells served as material resources for birch triterpenoid applications in further.
科研通智能强力驱动
Strongly Powered by AbleSci AI